Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.47
-0.03 (-0.16%)
Mar 6, 2026, 4:00 PM EST - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.20 billion as of March 6, 2026. Its market cap has increased by 59.56% in one year.
Market Cap
1.20B
Enterprise Value
911.75M
1-Year Change
59.56%
Ranking
Category
Stock Price
$18.47
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.20B, an increase of 28.79%. That is a compound annual growth rate of 18.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.20B | 30.15% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.32B |
| Immatics | 1.32B |
| EyePoint | 1.31B |
| Savara | 1.30B |
| MoonLake Immunotherapeutics | 1.30B |
| Septerna | 1.29B |
| Taysha Gene Therapies | 1.25B |
| AtaiBeckley | 1.23B |